At a glance
- Originator GlaxoSmithKline
- Class Anxiolytics
- Mechanism of Action Serotonin 2B receptor antagonists; Serotonin 2C receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 10 Jul 1998 Discontinued-Preclinical for Anxiety disorders in United Kingdom (Unknown route)
- 23 Sep 1997 New profile
- 23 Sep 1997 Preclinical development for Anxiety disorders in United Kingdom (Unknown route)